Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on October 14, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print October 14, 2004, doi: 10.1161/01.ATV.0000147406.00871.b3
A more recent version of this article appeared on December 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/12/2257    most recent
01.ATV.0000147406.00871.b3v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kartikasari, A. E.R.
Right arrow Articles by Marx, J. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kartikasari, A. E.R.
Right arrow Articles by Marx, J. J.M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*IRON

Submitted on June 14, 2004
Accepted on September 9, 2004

Intracellular Labile Iron Modulates Adhesion of Human Monocytes to Human Endothelial Cells

Apriliana E.R. Kartikasari ; Niki A. Georgiou ; Frank L.J. Visseren ; Henny van Kats-Renaud ; B. Sweder van Asbeck ; and Joannes J.M. Marx *

From the Eijkman-Winkler Center for Medical Microbiology (A.E.R.K., N.A.G., F.L.J.V., H.v.K.-R., B.S.v.A., J.J.M.M.), Infectious Diseases, and Inflammation and Eijkman Graduate School for Immunology and Infectious Diseases, and the Departments of Vascular Medicine (F.L.J.V.) and Internal Medicine (B.S.v.A.), University Medical Center Utrecht, The Netherlands.

* To whom correspondence should be addressed. E-mail: jmarx{at}azu.nl.

Objective--Elevated iron stores and high plasma iron concentration have been linked to an increased risk of atherosclerosis. Iron may thereby affect the interaction of monocytes to endothelium, an initial event in the formation of atherosclerotic plaques.

Methods and Results--Addition of 10 µmol/L non-transferrin-bound iron to the incubation medium caused a 2-fold increase in monocyte adhesion to human umbilical vein endothelial cells (HUVECs). A concordant increase in the expression of the following adhesion molecules was observed: vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and endothelial selectin on HUVECs as well as very late antigen-4, and lymphocyte function-associated antigen-1 on monocytes. The inclusion of either deferiprone or salicylaldehyde isonicotinoylhydrazone counteracted these effects. Intracellular iron chelation by deferoxamine was completed only after 10 hours of incubation, shown by reversal of iron-quenched intracellular calcein signal, and concurrently the effects of iron were blunted. The membrane-impermeable chelator, diethylenetriamine pentaaceticacid, failed to negate iron effects, even after 48 hours of treatment. Furthermore, only membrane-permeable superoxide or hydroxyl radical scavengers were capable of preventing HUVEC activation by iron.

Conclusions--Non-transferrin-bound iron increases the level of intracellular labile iron, which promotes monocyte recruitment to endothelium and may thereby contribute to the pathogenesis of atherosclerosis. Iron-induced adhesion molecule expression was observed, and this event may involve the production of oxygen radicals.


Key words: iron • atherosclerosis • monocytes • endothelium • adhesion molecules




This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
D. L. van der A, M. M. Rovers, D. E. Grobbee, J. J.M. Marx, J. Waalen, C. Ellervik, B. G. Nordestgaard, J. K. Olynyk, P. R. Mills, J. Shepherd, et al.
Mutations in the HFE Gene and Cardiovascular Disease Risk: An Individual Patient Data Meta-Analysis of 53 880 Subjects
Circ Cardiovasc Genet, October 1, 2008; 1(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Defrere, J.C. Lousse, R. Gonzalez-Ramos, S. Colette, J. Donnez, and A. Van Langendonckt
Potential involvement of iron in the pathogenesis of peritoneal endometriosis
Mol. Hum. Reprod., July 1, 2008; 14(7): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah
The Role of Iron in Diabetes and Its Complications
Diabetes Care, July 1, 2007; 30(7): 1926 - 1933.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li and B. Frei
Iron Chelation Inhibits NF-{kappa}B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity
Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2638 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Sullivan
Stored Iron and Vascular Reactivity
Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1532 - 1535.
[Full Text] [PDF]